CoChat

Better safe than sorry — why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study

Verbeek-Heida, Pietje M., Mathot, Edith F. · 2006 · Chronic Illness

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Background: Patients need to be informed not only about the effects and side-effects of their prescribed antidepressants such as selective serotonin reuptake inhibitors (SSRIs), but also about the consequences of stopping treatment with this medication. However, the professional guidelines on how to inform patients about stopping are not well developed and no consensus has yet been reached. This study focuses on the dilemmas involved in continuing or stopping the use of SSRIs from the perspective of the users and explores why these dilemmas tend to be solved by continuing rather than stopping. Methods: A qualitative study of the views of 16 SSRI users in The Netherlands was performed. Most interviews were conducted at the subject's own home, and all were tape-recorded with permission, and transcribed verbatim. The analysis is based on grounded theory, aiming at the systematic development of theories and hypotheses through the inspection of interview responses. Emerging themes were discussed and refined using the constant comparative method. Results: The SSRI users in this study had reached a certain balance after a period of trial and error. Feeling good could mean doing without these medicines, but could equally be because of the continuing use of these medicines. The SSRI users explained that it would be normal to stop at some time in the future. Some tried to stop but did not succeed, because they experienced serious drawbacks, so they continued, although they feared addiction and hoped that they would be able to stop at a later date. Others had never tried to stop, but said that they would like to because it is not normal to stay on this treatment forever. However, they were afraid that they would lose the balance that they had achieved in living a normal life. To support their choice of continuing SSRI use, they presented reasons why, in their case, this continuation was necessary. They all feared or had experiences with drawbacks, and were concerned and uncertain because of contradictory professional and lay messages about stopping the use of antidepressants, especially SSRIs. The fear and uncertainty about stopping without sufficient guidance were stronger than the fear and uncertainty about continuing. Users tended to stay on the safe side: better safe than sorry. Discussion: The fact that users mentioned their arguments for continuing so explicitly implies that they regarded their SSRI use as problematic and ambivalent. They feared that there would be problems in stopping, and mentioned disagreements on this subject among professionals and in the media. Users saw doctors as important in tackling their fears. Doctors could play an active role in the process of discontinuation, but they have to be aware that as soon as users lose their balance and are unable to live a normal life they will probably decide to continue. Greater agreement on guidelines is needed to support doctors in this matter, when both the patient and the doctor have decided to stop treatment.

Overview

Integrity signals

Registry

Crossref · 10.1177/17423953060020020801

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 11 references

Research works printed but not linked: 7

  1. 2004, Facts and figures
  2. Bouvy M., 1999, Pharm Weekblad, 134, 40
  3. van Balkom A., 2003, Pharmacotherapeutics panic disorders [in Dutch]
  4. Hansen EH, 1990, Cahiers Sociol Demograph Med, 30, 313
  5. Verbeek-Heida PM, 1992, De eigen wijsheid van de patient
  6. Britten N. Lay views of drugs and medicines, orthodox and unorthodox accounts. In: Williams SJ, Calnan M, eds. Modern medicine: lay perspectives and experiences . London: University College Press , 1996:48-73.
  7. vanderGeest S. Sceptical consumers: doubts about medicines. In: Reynolds Whyte S, VanderGeest SHA, eds. Social lives of medicines. Cambridge: Cambrridge University Press, 2002: 63—76.

Cited by

See all 83

Metadata

Authors
Verbeek-Heida, P. M., & Mathot, E. F.
Affiliations
University of Amsterdam (NL)
Venue
Chronic Illness
Published
2006-06
Volume
2
Issue
2
Pages
133-142
ISSN
  • 1742-3953 (ISSN-L)
  • 1745-9206
OpenAlex
W2022766484
Cited by
75
References
11
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 6 · 2018: 10 · 2017: 7 · 2016: 5 · 2015: 3 · 2014: 5 · 2013: 3 · 2012: 1
FWCI
0.84
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Chronic Illness (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
Keywords
selective serotonin reuptake inhibitors, antidepressant discontinuation, patient perspectives, fear of addiction, patient-physician communication, patient education, medication adherence, depression, shared decision-making
MeSH terms
Adult, Aged, Aged, 80 and over, Decision Making, Depression, Female, Humans, Male, Middle Aged, Patient Compliance, Patient Satisfaction, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation, Qualitative Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Better safe than sorry — why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study. https://app.cochat.ai/papers/10.1177/17423953060020020801
The paper
Verbeek-Heida, P. M., & Mathot, E. F. (2006). Better safe than sorry — why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study. Chronic Illness. https://doi.org/10.1177/17423953060020020801

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.